Georgina Correia-da-Silva

14PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCharacterisation of biological macromoleculesGene expression (incl. microarray and other genome-wide approaches)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 25, 2025
New Promising Steroidal Aromatase Inhibitors with Multi-Target Action on Estrogen and Androgen Receptors for Breast Cancer Treatment.

Cristina Amaral, Cristina F Almeida, Maria João Valente

|Sep 28, 2024
Molecular Targets of Minor Cannabinoids in Breast Cancer: In Silico and In Vitro Studies.

Cristina Ferreira Almeida, Andreia Palmeira, Maria João Valente

|May 15, 2024
Cannabidivarin and cannabigerol induce unfolded protein response and angiogenesis dysregulation in placental trophoblast HTR-8/SVneo cells.

Patrícia Alves, Cristina Amaral, Marina S Gonçalves

|Feb 24, 2024
Understanding Hypertriglyceridemia: Integrating Genetic Insights.

Mara Alves, Francisco Laranjeira, Georgina Correia-da-Silva

|Jul 14, 2023
In Vitro Effects of Combining Genistein with Aromatase Inhibitors: Concerns Regarding Its Consumption during Breast Cancer Treatment.

Patrícia H A Bezerra, Cristina Amaral, Cristina F Almeida

|May 13, 2023
Cannabidiol as a Promising Adjuvant Therapy for Estrogen Receptor-Positive Breast Tumors: Unveiling Its Benefits with Aromatase Inhibitors.

Cristina Ferreira Almeida, Natércia Teixeira, Maria João Valente

Pageof 3

Frequent Collaborators

4 joint publications

Maria João Valente

4 joint publications

Anne Marie Vinggaard

2 joint publications

Elisiário Tavares-da-Silva

1 joint publications

Cristina Amaral